Literature DB >> 18300344

Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production.

Riina-A Kekkonen1, Elina Kajasto, Minja Miettinen, Ville Veckman, Riitta Korpela, Ilkka Julkunen.   

Abstract

AIM: To investigate the capacity of potentially probiotic strains from six bacterial genera to induce cytokine production alone or in combinations in order to identify potential enhancing or synergistic effects in order to select probiotic bacteria for in vivo purposes.
METHODS: Cytokine production in human peripheral blood mononuclear cells (PBMC) in response to stimulation with eleven different potentially probiotic bacterial strains from Streptococcus, Lactobacillus, Bifidobacterium, Lactococcus, Leuconostoc and Propionibacterium genera was analysed. Production and mRNA expression of TNF-alpha, IL-12, IFN-gamma and IL-10 were determined by ELISA and Northern blotting, respectively.
RESULTS: All tested bacteria induced TNF-alpha production. The best inducers of Th1 type cytokines IL-12 and IFN-gamma were Streptococcus and Leuconostoc strains. All Bifidobacterium and Propionibacterium strains induced higher IL-10 production than other studied bacteria. Stimulation of PBMC with any bacterial combinations did not result in enhanced cytokine production suggesting that different bacteria whether gram-positive or gram-negative compete with each other during host cell interactions.
CONCLUSION: The probiotic S. thermophilus and Leuconostoc strains are more potent inducers of Th1 type cytokines IL-12 and IFN-gamma than the probiotic Lactobacillus strains. Bacterial combinations did not result in enhanced cytokine production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300344      PMCID: PMC2690666          DOI: 10.3748/wjg.14.1192

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  43 in total

1.  Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets.

Authors:  D Haller; S Blum; C Bode; W P Hammes; E J Schiffrin
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial.

Authors:  M Viljanen; E Savilahti; T Haahtela; K Juntunen-Backman; R Korpela; T Poussa; T Tuure; M Kuitunen
Journal:  Allergy       Date:  2005-04       Impact factor: 13.146

3.  Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway.

Authors:  J Pirhonen; T Sareneva; M Kurimoto; I Julkunen; S Matikainen
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

4.  Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor.

Authors:  U Gubler; A O Chua; D S Schoenhaut; C M Dwyer; W McComas; R Motyka; N Nabavi; A G Wolitzky; P M Quinn; P C Familletti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

5.  Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production.

Authors:  C Hessle; L A Hanson; A E Wold
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

6.  Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production.

Authors:  C Hessle; B Andersson; A E Wold
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Probiotics in the management of atopic eczema.

Authors:  E Isolauri; T Arvola; Y Sütas; E Moilanen; S Salminen
Journal:  Clin Exp Allergy       Date:  2000-11       Impact factor: 5.018

8.  Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria.

Authors:  M Miettinen; J Vuopio-Varkila; K Varkila
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

9.  Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells.

Authors:  M Miettinen; S Matikainen; J Vuopio-Varkila; J Pirhonen; K Varkila; M Kurimoto; I Julkunen
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.

Authors:  K Kajander; E Myllyluoma; M Rajilić-Stojanović; S Kyrönpalo; M Rasmussen; S Järvenpää; E G Zoetendal; W M de Vos; H Vapaatalo; R Korpela
Journal:  Aliment Pharmacol Ther       Date:  2007-10-05       Impact factor: 8.171

View more
  32 in total

1.  Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa.

Authors:  Christine Bäuerl; Marta Llopis; María Antolín; Vicente Monedero; Manuel Mata; Manuel Zúñiga; Francisco Guarner; Gaspar Pérez Martínez
Journal:  Genes Nutr       Date:  2012-06-06       Impact factor: 5.523

Review 2.  Reporter systems for in vivo tracking of lactic acid bacteria in animal model studies.

Authors:  Winschau F van Zyl; Shelly M Deane; Leon M T Dicks
Journal:  Gut Microbes       Date:  2015

3.  Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo.

Authors:  Benoît Foligné; Stéphanie-Marie Deutsch; Jérôme Breton; Fabien J Cousin; Joëlle Dewulf; Michel Samson; Bruno Pot; Gwénaël Jan
Journal:  Appl Environ Microbiol       Date:  2010-10-22       Impact factor: 4.792

4.  Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.

Authors:  Benoît Foligné; Joëlle Dewulf; Pascal Vandekerckove; Georges Pignède; Bruno Pot
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

5.  rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant.

Authors:  Claudia Petrarca; Emanuela Clemente; Valentina Toto; Manuela Iezzi; Cosmo Rossi; Stefania Zanotta; Gianni Mistrello; Ivan Zanoni; Francesca Granucci; Stefania Arioli; Diego Mora; Simone Guglielmetti; Roberto Paganelli; Mario Di Gioacchino
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

Review 6.  Therapeutical use of probiotic formulations in clinical practice.

Authors:  T Iannitti; B Palmieri
Journal:  Clin Nutr       Date:  2010-06-23       Impact factor: 7.324

7.  Effect of Lactobacillus casei on the Production of Pro-Inflammatory Markers in Streptozotocin-Induced Diabetic Rats.

Authors:  A Zarfeshani; H Khaza'ai; R Mohd Ali; Z Hambali; K W J Wahle; M S A Mutalib
Journal:  Probiotics Antimicrob Proteins       Date:  2011-12       Impact factor: 4.609

8.  Potential probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 cells and peripheral blood mononuclear cells and impacts the human gut microbiota in an in vitro colonic model system.

Authors:  Simone Maccaferri; Annett Klinder; Patrizia Brigidi; Piero Cavina; Adele Costabile
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

9.  Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages.

Authors:  Minja Miettinen; Taija E Pietilä; Riina A Kekkonen; Matti Kankainen; Sinikka Latvala; Jaana Pirhonen; Pamela Österlund; Riitta Korpela; Ilkka Julkunen
Journal:  Gut Microbes       Date:  2012-08-16

10.  Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells.

Authors:  Sinikka Latvala; Taija-E Pietila; Ville Veckman; Riina-A Kekkonen; Soile Tynkkynen; Riitta Korpela; Ilkka Julkunen
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.